Cornerstone Planning Group
BIOA icon

Cornerstone Planning Group’s BioAge Labs BIOA Stock Holding History

Cornerstone Planning Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-102
Closed -$2.24K – 1793
2026
Q2 		$2.24K Hold
102
– – ﹤0.01% 1297
2026
Q1 		$1.7K Hold
102
– – ﹤0.01% 1331
2025
Q4 		$1.99K Buy
102
+2
+2% +$18 ﹤0.01% 1196
2025
Q3 		$725 Buy
+100
New +$468 ﹤0.01% 1393

Other funds holding BIOA

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
True Wealth Design
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

Cornerstone Planning Group's BIOA Position: Q3 2026 in Review

Cornerstone Planning Group sold out of BioAge Labs (BIOA) in Q3 2026, closing a stake of 102 shares — an estimated $2.24K sold.

Cornerstone Planning Group first reported a position in BIOA in Q3 2025 and held it in 4 quarters. The position peaked at $2.24K in Q2 2026. 11 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • Cornerstone Planning Group reported no remaining BioAge Labs position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 102 BioAge Labs shares in Q3 2026, an estimated $2.24K.
  • Cornerstone Planning Group first reported a position in BioAge Labs in Q3 2025 and held it in 4 quarters.
  • Cornerstone Planning Group's BioAge Labs position peaked at $2.24K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.